ABBV
53
-4
WDC
52
3
FOX
37
6
TRIP
57
5
T
60
-3
NWS
41
4
ECL
72
-2
TEL
63
2
HBAN
45
-2
EXPD
54
7
HCA
70
-3
SLB
50
4
CPB
65
11
NOC
47
-3
SYK
59
-5
IR
71
8
TROW
34
2
MPC
41
5
PYPL
47
2
MCHP
47
-2
ABBV
53
-4
WDC
52
3
FOX
37
6
TRIP
57
5
T
60
-3
NWS
41
4
ECL
72
-2
TEL
63
2
HBAN
45
-2
EXPD
54
7
HCA
70
-3
SLB
50
4
CPB
65
11
NOC
47
-3
SYK
59
-5
IR
71
8
TROW
34
2
MPC
41
5
PYPL
47
2
MCHP
47
-2
Financhill
Back

Novo Nordisk AS Quote, Financials, Valuation and Earnings

"The Next Apple?" - Mode's Growth Story is Turning Heads

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
43

NVO
Novo Nordisk AS

Last Price:
132.03
Seasonality Move:
4.32%

7 Day Trial

ALL ACCESS PASS

$ 7

Hint at where the next big move in the market will be this month

Spot the next big move with this free book from a hedge fund manager

Novo Nordisk AS Price Quote

$132.03
+0.03 (+0.02%)
(Updated: September 18, 2024 at 6:55 PM ET)

Novo Nordisk AS Key Stats

Sell
43
Novo Nordisk AS (NVO) is a Sell
Day range:
$131.80 - $135.16
52-week range:
$86.96 - $148.15
Dividend yield:
1.1%
P/E ratio:
48.83
P/S ratio:
15.78
P/B ratio:
36.38%
Volume:
3.5M
Avg. volume:
3.4M
1-year change:
38.63%
Market cap:
$587.6B
Revenue:
$33.7B
EPS:
$2.91

How Much Does Novo Nordisk AS Make?

Is Novo Nordisk AS Growing As A Company?

  • What Is Novo Nordisk AS's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.24%
  • What Is Novo Nordisk AS's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.03%

Novo Nordisk AS Stock Price Performance

  • Did Novo Nordisk AS Stock Go Up Last Month?
    Novo Nordisk AS share price went down by -2.14% last month
  • Did NVO's Share Price Rise Over The Last Year?
    NVO share price rose by 38.63% over the past 1 year

What Is Novo Nordisk AS 52-Week High & Low?

Novo Nordisk AS Price To Free Cash Flow

Is It Risky To Buy Novo Nordisk AS?

  • How Much Debt Does Novo Nordisk AS Have?
    Total long term debt quarterly is $8.2B
  • How Much Cash Does Novo Nordisk AS Have?
    Cash and short term investments quarterly total is $9B
  • What Is Novo Nordisk AS’s Book Value Per Share?
    Book value per share is 3.63

Is Novo Nordisk AS Cash Flow Positive?

  • What Is NVO Cash Flow From Operations?
    Cash flow from operations (TTM) is $16.6B
  • What Is Novo Nordisk AS’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$5.7B
  • What Is Novo Nordisk AS’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$6.5B

Novo Nordisk AS Return On Invested Capital

  • Is Management Doing A Good Job?
    NVO return on invested capital is 68.37%
  • What Is Novo Nordisk AS Return On Assets?
    ROA measures how assets are converting to revenues and is 28.81%
  • What Is NVO Return On Equity?
    ROE is a measure of profitability and is 89.79%

Novo Nordisk AS Earnings Date & Stock Price

Novo Nordisk AS Competitors

  • Who Are Novo Nordisk AS's Competitors?
    Below is a list of companies who compete with Novo Nordisk AS or are related in some way:
    • Adaptimmune Therapeutics PLC (ADAP)
    • Evaxion Biotech AS (EVAX)
    • Viking Therapeutics Inc (VKTX)
    • Verona Pharma PLC (VRNA)
    • Zealand Pharma AS (ZLDPF)

Novo Nordisk AS Dividend Yield

Novo Nordisk AS Analyst Estimates

YoY Growth Past Surprise
EPS: 2.65% -7.7%
Revenue: 23.79% -0.96%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 1
Sell Recommendations: 2
Price Target: 143.93
Upside from Last Price: 9.04%

Major Shareholders

  • How many NVO shares are owned by institutional investors?
    429.5M NVO shares are owned by institutional investors
  • How many NVO shares are owned by insiders?
    0 NVO shares are owned by insiders